12 papers
Tirzepatide
12 publications — 8 trials, 3 syntheses.
Il-bażi tal-evidenza
Dak li din is-sit huwa mibni fuqu, suġġett b'suġġett: kemm artikli, kemm huma trials, u kemm huma reċenti. Ġenerat mill-ġbir, għalhekk ma jistax jaħrab mill-evidenza nnifisha.
11 papers
GLP-1 mechanism
11 publications — 5 trials, 3 syntheses.
11 papers
Semaglutide weight
11 publications — 6 trials, 4 syntheses.
10 papers
Cardiovascular
10 publications — 3 trials, 6 syntheses.
10 papers
GLP-1 other
10 publications — 3 trials, 5 syntheses.
9 papers
Adverse effects
9 publications — 7 trials, 1 synthesis.
9 papers
Discontinuation
9 publications — 8 trials, 0 syntheses.
8 papers
Muscle loss
8 publications — 5 trials, 2 syntheses.
7 papers
Oral GLP-1
7 publications — 6 trials, 1 synthesis.
Qari relatat
Fasting Evidence
Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.
Metabolism Review
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Weight Loss Evidence
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep Evidence
Sleep, circadian rhythm and the wearables that claim to measure both.
Din il-paġna ġiet tradotta awtomatikament mill-Ingliż. Il-citazzjonijiet u n-numri mhumiex mibdula. Aqra l-original Ingliż jekk xi ħaġa taqra b'mod stramb. Aqra l-original Ingliż